FDA grants fast track status to Phanes’ spevatamig for advanced BTC

Phanes has expanded a clinical trial partnership with MSD to study spevatamig with pembrolizumab for BTC. Credit: PeopleImages / Shutterstock.com.



  • Phanes FDA spevatamig